Cephalexin 375mg ER Tablets

Cephalexin 375mg ER Tablets are a long-acting oral cephalosporin antibiotic used for susceptible respiratory, ear, skin and soft-tissue, and urinary infections. The extended-release tablet is designed for a different dosing pattern from conventional cephalexin capsules. Its antibacterial target remains the bacterial cell wall.
Swallow the extended-release tablet whole with a glass of water after meals. Do not divide, crush, powder or chew it. These long-acting tablets are commonly used twice daily; the selected strength and interval depend on the infection and kidney function, not on a conventional capsule schedule.
Cephalexin binds to penicillin-binding proteins and interrupts bacterial cell-wall synthesis. The weakened cell wall leads to death of susceptible bacteria.
Diarrhoea, nausea, indigestion, abdominal pain and vomiting can occur. Severe or persistent watery diarrhoea, blood in stools, a widespread blistering rash or swelling with breathing difficulty needs urgent attention.
Tell your doctor about previous serious reactions to cephalosporins or penicillins, kidney disease, antibiotic-associated colitis, pregnancy and breastfeeding. Probenecid can increase cephalexin exposure, and metformin or anticoagulant treatment may need monitoring. Confusion or seizures during treatment can be a sign of excessive exposure, particularly with kidney impairment.
Successful bacterial clearance allows fever, tenderness, urinary discomfort or local inflammation to improve according to the infection site. The clinical response depends on organism sensitivity and an adequate treatment course.
Not automatically. The release pattern and dosing interval differ. A switch must preserve an effective antibiotic exposure rather than only the same number of milligrams.
The manufacturer specifies after-meal administration for this formulation. This is more specific than the with-or-without-food instruction used for conventional cephalexin capsules.
No. The manufacturer states that the long-acting tablet should not be divided. A 375mg tablet is a separate presentation, not half of a split 750mg tablet.
No. Extended release changes medicine delivery, not its antibacterial spectrum. Viral respiratory infections do not become susceptible to an antibiotic because a longer-acting form is used.
Extended-release tablet: a tablet designed to release medicine over a prolonged period. Cephalosporin: a beta-lactam antibiotic class. Cefalexin: another spelling of cephalexin. Dosing interval: the time between scheduled doses; AR: Cephalexin 375mg أقراص ممتدة التحرر; FR: Cephalexin 375mg comprimés à libération prolongée; PT: Cephalexin 375mg comprimidos de libertação prolongada; ES: Cephalexin 375mg comprimidos de liberación prolongada; RU: Cephalexin 375mg таблетки пролонгированного высвобождения; ID: Cephalexin 375mg tablet lepas lambat; VI: Cephalexin 375mg viên nén giải phóng kéo dài; MS: Cephalexin 375mg tablet pelepasan berpanjangan; TL: Cephalexin 375mg tabletang may pinalawig na paglabas; ZH-SG: Cephalexin 375mg 缓释片
International B2B Enquiry
Send a structured B2B enquiry for Cephalexin 375mg ER Tablets under Antibiotics. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Cephalexin 375mg ER Tablets